Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:Hallucinogen |
| gptkbp:chemicalFormula |
C11H15NO2
|
| gptkbp:discoveredBy |
gptkb:Alexander_Shulgin
|
| gptkbp:effect |
psychedelic effects
stimulant effects |
| gptkbp:IUPACName |
2,6-dimethoxy-4,5-methylenedioxyamphetamine
|
| gptkbp:legalStatus |
uncontrolled (in most countries)
|
| gptkbp:mentionedIn |
gptkb:PiHKAL
|
| gptkbp:molecularWeight |
193.24 g/mol
|
| gptkbp:relatedTo |
gptkb:amphetamine
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:bfsParent |
gptkb:CDKN1A_gene
gptkb:WAF1_gene gptkb:p21_(CDKN1A) |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
MDA-6
|